Description: American CryoStem Corporation is a developer and marketer of adipose tissue-based cellular technologies and related services. The Company focuses on clinical processing, commercial bio-banking and application development for adipose (fat) tissue and autologous adipose-derived regenerative cells (ADRCs). The Company's products and services include CELLECT, ATGRAFT, ATCELL, ACSelerate, ACS Laboratories, Autokine-CM and International Licensing Program. The Company is in the business of collecting adipose tissue, processing it to separate the adult stem cells, and preparing such stem cells for long-term storage. Its ATGRAFT procedures include breast reconstruction, layered augmentation, buttocks enhancement or volume corrections of the hands, feet, face and neck areas. Its ACSelerate product is engaged in manufacturing various versions of its ACSelerate cell culture media, which includes ACSelerate-MAX, ACSelerate-SFM, ACSelerate-CY, ACSelerate-MY, ACSelerate-CP and ACSelerate-TR.
Home Page: www.americancryostem.com
1 Meridian Road
Eatontown,
NJ
07724
United States
Phone:
732 747 1007
Officers
| Name | Title |
|---|---|
| Mr. John S. Arnone | Chairman, Pres & CEO |
| Mr. Anthony Francis Dudzinski Jr. | COO, Treasurer, Sec. & Director |
| Donald Devine CPA | Head of Accounting Department & Controller |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1258.7036 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 4 |